Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1924 1
1965 2
1966 2
1968 1
1969 1
1970 1
1971 3
1973 1
1974 3
1975 2
1977 4
1979 1
1980 2
1981 5
1982 4
1983 3
1984 2
1985 7
1986 7
1987 4
1988 11
1989 4
1990 3
1991 9
1992 8
1993 12
1994 5
1995 5
1996 12
1997 23
1998 15
1999 17
2000 5
2001 13
2002 15
2003 19
2004 30
2005 42
2006 43
2007 61
2008 42
2009 45
2010 66
2011 94
2012 108
2013 117
2014 154
2015 177
2016 156
2017 180
2018 222
2019 207
2020 337
2021 483
2022 533
2023 457
2024 495
2025 583
2026 365

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,674 results

Results by year

Filters applied: . Clear all
Page 1
Adapting health, economic and social policies to address population aging in China.
Fang EF, Fang Y, Chen G, Wang HL, Zhang J, Wu C, Liao J, Xie C, Liu X, Wang K, Liu Y, Yang G, Wang Q, He LT, Li J, Chen HZ, Kang L, Jiang Y, Su H, Jiang H, He N, Tao J, Leng SX, Siow RC, Liu C, Khan HTA, Liu Y, Kato H, Sasaki T, Kim JI, Maier AB, Zhang L, Rasmussen LJ, Woo J, Wu J, Zou H. Fang EF, et al. Among authors: khan hta. Nat Aging. 2025 Nov;5(11):2176-2187. doi: 10.1038/s43587-025-00999-8. Epub 2025 Oct 31. Nat Aging. 2025. PMID: 41174222 Review.
Radiomics Quality Score 2.0: towards radiomics readiness levels and clinical translation for personalized medicine.
Lambin P, Woodruff HC, Mali SA, Zhong X, Kuang S, Lavrova E, Khan H, Lekadir K, Zwanenburg A, Deasy J, Bobowicz M, Marti-Bonmati L, Maidment A, Dumontier M, Kinahan PE, Nobel JM, Amirrajab S, Salahuddin Z. Lambin P, et al. Among authors: khan h. Nat Rev Clin Oncol. 2025 Nov;22(11):831-846. doi: 10.1038/s41571-025-01067-1. Epub 2025 Sep 3. Nat Rev Clin Oncol. 2025. PMID: 40903523 Review.
Replication-stress-induced chromatin loops protect fork stability.
Gaggioli V, Sengupta K, Choudhury A, Paulson J, Kuthethur R, Bakker C, Li J, Lo CSY, Whale A, van den Berg J, Asua Intxausti L, Gil-Lanza N, Galván-Femenía I, Manolika EM, Eswaran S, Khan HN, Ferré E, Stik G, van Oudenaarden A, Papantonis A, Houseley J, Sridharan S, Chaudhuri AR, Bayona-Feliu A, Taneja N. Gaggioli V, et al. Among authors: khan hn. Nature. 2026 Jul 1. doi: 10.1038/s41586-026-10695-1. Online ahead of print. Nature. 2026. PMID: 42386978
30th Anniversary of Phytomedicine: Looking Back and Forth.
Efferth T, Zacchino S, Georgiev M, He RR, Shen X, Albrecht U, Belwal T, Bhutia SK, Chatterjee M, Chen J, Chen ZY, Cho W, Devi SI, Eid AH, Orhan IE, Gao Y, Hosseinzadeh H, Hua Q, Khan H, Kuete V, Li M, Lyu A, Lyu H, Mehan S, Mukherjee PK, Pan H, Panossian A, Peng C, Ramamoorthy S, Rijo P, Sen R, Wong VKW, Wang XJ, Wei ZJ, Xiao J, Xie Y, Yu Z, Zhou H, Bahramimehr F, Boulos JC, Özenver N, Yücer R. Efferth T, et al. Among authors: khan h. Phytomedicine. 2025 Dec;149:157525. doi: 10.1016/j.phymed.2025.157525. Epub 2025 Nov 6. Phytomedicine. 2025. PMID: 41224575 No abstract available.
Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: a validated risk stratification.
Lieve KV, van der Werf C, Kallas D, Denjoy I, Bos JM, Aiba T, Behr ER, van den Berg MP, Bergeman AT, Blom NA, Borggrefe M, Brugada R, Carrillo Mora LM, Chorin E, Crotti L, Davis A, Drago F, Dusi V, Extramiana F, Franciosi S, Giudicessi JR, González Llopis FÁ, Haugaa KH, van den Heuvel F, Horie M, Ingles J, Kammeraad J, Kannankeril PJ, Khan HR, Krahn AD, MacIntyre C, Maltret A, Marjamaa A, Ohno S, Peltenburg PJ, Perez GJ, Probst V, Roberts JD, Robyns T, Rootwelt-Norberg C, Roses I Noguer F, Roston TM, Rydberg A, Sacher F, Sarquella-Brugada G, Schwartz PJ, Semsarian C, Shimizu W, Starling L, Sumitomo N, Skinner JR, Tavacova T, Tfelt-Hansen J, Till JA, Yap SC, Wada Y, Wangüemert F, Zorio E, Ackerman MJ, Leenhardt A, Sanatani S, Tanck MW, Wilde AA. Lieve KV, et al. Among authors: khan hr. Eur Heart J. 2025 Dec 19:ehaf965. doi: 10.1093/eurheartj/ehaf965. Online ahead of print. Eur Heart J. 2025. PMID: 41416846
XPO1 inhibition in KRAS-mutant cancers: time for clinical trials but how?
Nagasaka M, Khan HY, Luo F, Al-Hallak MN, Saif MW, Mohammad RM, Azmi AS. Nagasaka M, et al. Among authors: khan hy. Transl Lung Cancer Res. 2025 Aug 31;14(8):2895-2899. doi: 10.21037/tlcr-2025-432. Epub 2025 Aug 13. Transl Lung Cancer Res. 2025. PMID: 40948839 Free PMC article. No abstract available.
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence.
Soeung M, Yan X, Zanca C, Qian J, Karki M, Duan F, Khan H, Zhang L, Peng DH, Williams M, He R, Chen Z, Perelli L, Chen J, Tidwell RS, Chauhan PK, Le CN, Lam TNA, Bhattacharya N, Shah R, Ho IL, Gay JP, Carrillo CC, Feng N, Le K, Gao G, Perry TL, Mseeh F, Jiang Y, Xu QA, Zacharias NM, Sheth RA, Bathala TK, Rao P, Daw NC, Tripathi DN, Walker CL, Mohammad MM, Zhang J, Han G, Chu Y, Wang R, Dang M, Dai E, Peng F, Liu Y, Jadhav A, Lang W, Arrechedera CA, Clemente LC, Parra ER, Lu H, Haymaker CL, Wistuba II, Futreal A, Viale A, Soth MJ, Jones P, Marszalek JR, Heffernan T, Draetta GF, Tannir NM, Gao J, Wang L, Genovese G, Msaouel P. Soeung M, et al. Among authors: khan h. Nat Commun. 2025 Nov 25;16(1):10474. doi: 10.1038/s41467-025-65462-z. Nat Commun. 2025. PMID: 41290625 Free PMC article. Clinical Trial.
4,674 results